APPLICATION
ANDA071777
TYPE
ANDA
ORIGINAL APPROVAL
1987-07-14
LATEST ACTION
1988-03-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
CLORAZEPATE DIPOTASSIUMDiscontinued
CLORAZEPATE DIPOTASSIUM 3.75MG · CAPSULE · ORAL
Approval history
1988-03-10Labeling · Supplement 2AP
1987-07-14OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.